Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $1.27 Million - $2.08 Million
-12,500 Reduced 71.43%
5,000 $593,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $1.49 Million - $2.02 Million
17,500 New
17,500 $1.86 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $158,074 - $257,957
-700 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $155,330 - $339,129
700 New
700 $269,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.